

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 5.55922256 |
| 2 | NADH metabolic process (GO:0006734) | 5.00681436 |
| 3 | protein neddylation (GO:0045116) | 4.56943724 |
| 4 | succinate metabolic process (GO:0006105) | 4.54347299 |
| 5 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.54193558 |
| 6 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.51418068 |
| 7 | regulation of coenzyme metabolic process (GO:0051196) | 4.16862882 |
| 8 | regulation of cofactor metabolic process (GO:0051193) | 4.16862882 |
| 9 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.11972209 |
| 10 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.99215652 |
| 11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.97682459 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 3.95078163 |
| 13 | oxaloacetate metabolic process (GO:0006107) | 3.94706595 |
| 14 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.94630208 |
| 15 | positive regulation of mitochondrial fission (GO:0090141) | 3.91560995 |
| 16 | detection of calcium ion (GO:0005513) | 3.88454043 |
| 17 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.88079935 |
| 18 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.85607178 |
| 19 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.81833756 |
| 20 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.78407244 |
| 21 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.61533960 |
| 22 | cullin deneddylation (GO:0010388) | 3.60861887 |
| 23 | cell communication by electrical coupling (GO:0010644) | 3.56804873 |
| 24 | regulation of cell communication by electrical coupling (GO:0010649) | 3.56354979 |
| 25 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.50875676 |
| 26 | vocalization behavior (GO:0071625) | 3.50788321 |
| 27 | activation of protein kinase A activity (GO:0034199) | 3.49942097 |
| 28 | synaptic vesicle maturation (GO:0016188) | 3.43665281 |
| 29 | glutamate secretion (GO:0014047) | 3.39442767 |
| 30 | oxidative phosphorylation (GO:0006119) | 3.38135598 |
| 31 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.37266658 |
| 32 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.35676905 |
| 33 | negative regulation of response to food (GO:0032096) | 3.35656454 |
| 34 | negative regulation of appetite (GO:0032099) | 3.35656454 |
| 35 | carnitine shuttle (GO:0006853) | 3.33507879 |
| 36 | regulation of synaptic vesicle transport (GO:1902803) | 3.31644325 |
| 37 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.30711399 |
| 38 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.30650974 |
| 39 | neuronal action potential propagation (GO:0019227) | 3.30252795 |
| 40 | protein deneddylation (GO:0000338) | 3.28538360 |
| 41 | regulation of membrane repolarization (GO:0060306) | 3.26330287 |
| 42 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.21503335 |
| 43 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.19844128 |
| 44 | respiratory electron transport chain (GO:0022904) | 3.19770569 |
| 45 | striatum development (GO:0021756) | 3.15944746 |
| 46 | neurotransmitter secretion (GO:0007269) | 3.14824760 |
| 47 | regulation of sulfur metabolic process (GO:0042762) | 3.14803931 |
| 48 | cardiac muscle contraction (GO:0060048) | 3.14002354 |
| 49 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.13769452 |
| 50 | electron transport chain (GO:0022900) | 3.12865100 |
| 51 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.10542325 |
| 52 | regulation of synapse structural plasticity (GO:0051823) | 3.07661995 |
| 53 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.06711922 |
| 54 | regulation of relaxation of muscle (GO:1901077) | 3.06092391 |
| 55 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.04600869 |
| 56 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.04410159 |
| 57 | lysine metabolic process (GO:0006553) | 3.03928958 |
| 58 | lysine catabolic process (GO:0006554) | 3.03928958 |
| 59 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.00601386 |
| 60 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.99934190 |
| 61 | cell communication involved in cardiac conduction (GO:0086065) | 2.99480441 |
| 62 | negative regulation of heart rate (GO:0010459) | 2.97392085 |
| 63 | cardiac myofibril assembly (GO:0055003) | 2.97039957 |
| 64 | behavioral response to nicotine (GO:0035095) | 2.95731790 |
| 65 | membrane depolarization during action potential (GO:0086010) | 2.93568368 |
| 66 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.92100183 |
| 67 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.92100183 |
| 68 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.91981789 |
| 69 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.91389319 |
| 70 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.89721767 |
| 71 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.89323172 |
| 72 | NADH dehydrogenase complex assembly (GO:0010257) | 2.89323172 |
| 73 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.89323172 |
| 74 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.89174085 |
| 75 | fatty acid transmembrane transport (GO:1902001) | 2.88838884 |
| 76 | locomotory exploration behavior (GO:0035641) | 2.87925244 |
| 77 | neurotransmitter uptake (GO:0001504) | 2.87597763 |
| 78 | dopamine transport (GO:0015872) | 2.86351948 |
| 79 | response to pheromone (GO:0019236) | 2.83772930 |
| 80 | cardiac conduction (GO:0061337) | 2.83706739 |
| 81 | neuromuscular process controlling posture (GO:0050884) | 2.83353461 |
| 82 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.83067368 |
| 83 | aspartate family amino acid catabolic process (GO:0009068) | 2.82961126 |
| 84 | synaptic vesicle endocytosis (GO:0048488) | 2.80504670 |
| 85 | 2-oxoglutarate metabolic process (GO:0006103) | 2.80214813 |
| 86 | sarcomere organization (GO:0045214) | 2.79284409 |
| 87 | regulation of protein glycosylation (GO:0060049) | 2.79093736 |
| 88 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.78899935 |
| 89 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.76123889 |
| 90 | protein localization to synapse (GO:0035418) | 2.75386525 |
| 91 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.74857408 |
| 92 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.74186679 |
| 93 | ATP synthesis coupled proton transport (GO:0015986) | 2.74186679 |
| 94 | cellular potassium ion homeostasis (GO:0030007) | 2.72805014 |
| 95 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.72288512 |
| 96 | carnitine transmembrane transport (GO:1902603) | 2.71988331 |
| 97 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.71886182 |
| 98 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.71886182 |
| 99 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.71512891 |
| 100 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.71512891 |
| 101 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.68696900 |
| 102 | tetrapyrrole biosynthetic process (GO:0033014) | 2.68248664 |
| 103 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.68181021 |
| 104 | neuron-neuron synaptic transmission (GO:0007270) | 2.67631069 |
| 105 | striated muscle contraction (GO:0006941) | 2.66819640 |
| 106 | myofibril assembly (GO:0030239) | 2.65846320 |
| 107 | gluconeogenesis (GO:0006094) | 2.65450695 |
| 108 | regulation of actin filament-based movement (GO:1903115) | 2.65290743 |
| 109 | glycine transport (GO:0015816) | 2.65060916 |
| 110 | negative regulation of cation channel activity (GO:2001258) | 2.64505544 |
| 111 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.64059400 |
| 112 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.63925164 |
| 113 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.63596457 |
| 114 | ubiquinone biosynthetic process (GO:0006744) | 2.62944587 |
| 115 | regulation of cation channel activity (GO:2001257) | 2.62492260 |
| 116 | regulation of mitochondrial fission (GO:0090140) | 2.61920140 |
| 117 | carnitine transport (GO:0015879) | 2.61786196 |
| 118 | amino-acid betaine transport (GO:0015838) | 2.61786196 |
| 119 | ubiquinone metabolic process (GO:0006743) | 2.60379350 |
| 120 | relaxation of cardiac muscle (GO:0055119) | 2.59551164 |
| 121 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.58775374 |
| 122 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.58694694 |
| 123 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.58694694 |
| 124 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.58265418 |
| 125 | regulation of cilium movement (GO:0003352) | 2.58169415 |
| 126 | C4-dicarboxylate transport (GO:0015740) | 2.57543704 |
| 127 | proline transport (GO:0015824) | 2.56850135 |
| 128 | respiratory chain complex IV assembly (GO:0008535) | 2.55337870 |
| 129 | chaperone-mediated protein transport (GO:0072321) | 2.53088393 |
| 130 | protein localization to cilium (GO:0061512) | 2.50925779 |
| 131 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.50751902 |
| 132 | protein-cofactor linkage (GO:0018065) | 2.48472673 |
| 133 | cellular response to leptin stimulus (GO:0044320) | 2.47943393 |
| 134 | gamma-aminobutyric acid transport (GO:0015812) | 2.45944779 |
| 135 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.45129715 |
| 136 | protein complex biogenesis (GO:0070271) | 2.44317656 |
| 137 | response to insecticide (GO:0017085) | 2.43807627 |
| 138 | behavioral response to cocaine (GO:0048148) | 2.42663056 |
| 139 | neuron cell-cell adhesion (GO:0007158) | 2.42344381 |
| 140 | L-methionine salvage (GO:0071267) | 2.41532646 |
| 141 | L-methionine biosynthetic process (GO:0071265) | 2.41532646 |
| 142 | amino acid salvage (GO:0043102) | 2.41532646 |
| 143 | inositol phosphate catabolic process (GO:0071545) | 2.41354135 |
| 144 | relaxation of smooth muscle (GO:0044557) | 2.36109524 |
| 145 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.35850282 |
| 146 | neurofilament cytoskeleton organization (GO:0060052) | 2.31690325 |
| 147 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.30352940 |
| 148 | maturation of 5.8S rRNA (GO:0000460) | 2.29083745 |
| 149 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.28971931 |
| 150 | regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108) | 2.27153226 |
| 151 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.25556937 |
| 152 | negative regulation of neurotransmitter transport (GO:0051589) | 2.24700603 |
| 153 | response to leptin (GO:0044321) | 2.24561523 |
| 154 | protein localization to mitochondrion (GO:0070585) | 2.24021668 |
| 155 | inositol phosphate dephosphorylation (GO:0046855) | 2.23941152 |
| 156 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.23941152 |
| 157 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.23195355 |
| 158 | synaptic transmission, glutamatergic (GO:0035249) | 2.23170876 |
| 159 | regulation of hexokinase activity (GO:1903299) | 2.22994112 |
| 160 | regulation of glucokinase activity (GO:0033131) | 2.22994112 |
| 161 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.21242950 |
| 162 | nucleobase catabolic process (GO:0046113) | 2.20806387 |
| 163 | regulation of sequestering of triglyceride (GO:0010889) | 2.20695712 |
| 164 | fatty acid elongation (GO:0030497) | 2.19542409 |
| 165 | protein targeting to mitochondrion (GO:0006626) | 2.18739883 |
| 166 | glycosphingolipid biosynthetic process (GO:0006688) | 2.17888876 |
| 167 | platelet dense granule organization (GO:0060155) | 2.17175728 |
| 168 | peptidyl-cysteine modification (GO:0018198) | 2.16710757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.71036523 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.26986263 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.24669334 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.65317991 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.52808645 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.52166331 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.51446132 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.50882439 |
| 9 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.35893626 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.33566972 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.31983914 |
| 12 | FUS_26573619_Chip-Seq_HEK293_Human | 2.28052001 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.23299027 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.21800425 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.21058582 |
| 16 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18258061 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.16258220 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.14735126 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.12057839 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.09946362 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.07359385 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.07359385 |
| 23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.04265688 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.00766717 |
| 25 | EWS_26573619_Chip-Seq_HEK293_Human | 1.98981212 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.96666085 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.91054313 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.90139364 |
| 29 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.88584956 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.86326034 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.84640413 |
| 32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.80884885 |
| 33 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.76183158 |
| 34 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.75779959 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70991559 |
| 36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68283148 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.67117823 |
| 38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.67040616 |
| 39 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64729561 |
| 40 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.64577440 |
| 41 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.64570963 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62076649 |
| 43 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61644737 |
| 44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.61613831 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60279102 |
| 46 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.58125905 |
| 47 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.52063195 |
| 48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.49779474 |
| 49 | VDR_22108803_ChIP-Seq_LS180_Human | 1.49430637 |
| 50 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48123132 |
| 51 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.48026921 |
| 52 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.47983329 |
| 53 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.47608163 |
| 54 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.46590999 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.46126341 |
| 56 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45989437 |
| 57 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.45913877 |
| 58 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.45140918 |
| 59 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.44463729 |
| 60 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.44329719 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.40253277 |
| 62 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.40013519 |
| 63 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38248226 |
| 64 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.37590257 |
| 65 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.36913624 |
| 66 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34525375 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.34382315 |
| 68 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.33289667 |
| 69 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31311092 |
| 70 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.30191305 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29703986 |
| 72 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.26765985 |
| 73 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.25201196 |
| 74 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.24273822 |
| 75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.23612397 |
| 76 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.23420101 |
| 77 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23118227 |
| 78 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22951949 |
| 79 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.22889650 |
| 80 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.22724727 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22387858 |
| 82 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.22235788 |
| 83 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22140239 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21075668 |
| 85 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.20526575 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20526009 |
| 87 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.20474270 |
| 88 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.20295594 |
| 89 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19948284 |
| 90 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.18720065 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.18189005 |
| 92 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.18189005 |
| 93 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.15983278 |
| 94 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.15805076 |
| 95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15018363 |
| 96 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.13180621 |
| 97 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.13119008 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12851559 |
| 99 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.11903313 |
| 100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11624172 |
| 101 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.11315568 |
| 102 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10612263 |
| 103 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10573495 |
| 104 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.10570477 |
| 105 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.10452847 |
| 106 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10393900 |
| 107 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.10021973 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09477953 |
| 109 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.08010657 |
| 110 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.06939564 |
| 111 | AR_19668381_ChIP-Seq_PC3_Human | 1.06143258 |
| 112 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.05254814 |
| 113 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05234011 |
| 114 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04769549 |
| 115 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04664730 |
| 116 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04164649 |
| 117 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03789530 |
| 118 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03526941 |
| 119 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.02657763 |
| 120 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.02657763 |
| 121 | STAT3_23295773_ChIP-Seq_U87_Human | 1.02557150 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01914356 |
| 123 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.00370077 |
| 124 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00319560 |
| 125 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00258760 |
| 126 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00198343 |
| 127 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99445911 |
| 128 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99415518 |
| 129 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97941868 |
| 130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97776778 |
| 131 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97481296 |
| 132 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97033170 |
| 133 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96959404 |
| 134 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.96889210 |
| 135 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96641118 |
| 136 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96578976 |
| 137 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96408828 |
| 138 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93304800 |
| 139 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92982913 |
| 140 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91644761 |
| 141 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.90319708 |
| 142 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.89426155 |
| 143 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.89359280 |
| 144 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87931450 |
| 145 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87367403 |
| 146 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86740990 |
| 147 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86691773 |
| 148 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86234223 |
| 149 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.85600428 |
| 150 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.84342097 |
| 151 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.84091254 |
| 152 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83781943 |
| 153 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.83463924 |
| 154 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.83094400 |
| 155 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.82739337 |
| 156 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82091263 |
| 157 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.81793090 |
| 158 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81535080 |
| 159 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.81480375 |
| 160 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.81459308 |
| 161 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.81459308 |
| 162 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80612145 |
| 163 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78328897 |
| 164 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77849155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.23802597 |
| 2 | MP0003646_muscle_fatigue | 3.96801612 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.77524967 |
| 4 | MP0004215_abnormal_myocardial_fiber | 3.23018955 |
| 5 | MP0000751_myopathy | 3.14176943 |
| 6 | MP0002102_abnormal_ear_morphology | 2.83205873 |
| 7 | MP0004147_increased_porphyrin_level | 2.81327496 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.58207640 |
| 9 | MP0004036_abnormal_muscle_relaxation | 2.51792094 |
| 10 | MP0004084_abnormal_cardiac_muscle | 2.50865325 |
| 11 | MP0003880_abnormal_central_pattern | 2.50640083 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.50428528 |
| 13 | MP0000749_muscle_degeneration | 2.43487116 |
| 14 | MP0004130_abnormal_muscle_cell | 2.42677549 |
| 15 | MP0002822_catalepsy | 2.38538434 |
| 16 | MP0009745_abnormal_behavioral_response | 2.23226169 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 2.19779607 |
| 18 | MP0009046_muscle_twitch | 2.17200662 |
| 19 | MP0006036_abnormal_mitochondrial_physio | 2.13613584 |
| 20 | MP0001188_hyperpigmentation | 2.10763831 |
| 21 | MP0004484_altered_response_of | 1.98979094 |
| 22 | MP0002064_seizures | 1.98187764 |
| 23 | MP0002063_abnormal_learning/memory/cond | 1.97850034 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.97527226 |
| 25 | MP0000013_abnormal_adipose_tissue | 1.96745062 |
| 26 | MP0004043_abnormal_pH_regulation | 1.93161887 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.90161975 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.86724058 |
| 29 | MP0004270_analgesia | 1.82114748 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.81569499 |
| 31 | MP0005620_abnormal_muscle_contractility | 1.80968884 |
| 32 | MP0002736_abnormal_nociception_after | 1.78141944 |
| 33 | MP0001984_abnormal_olfaction | 1.78071411 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.78061089 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.73223800 |
| 36 | MP0005330_cardiomyopathy | 1.72111343 |
| 37 | MP0002272_abnormal_nervous_system | 1.72047518 |
| 38 | MP0002972_abnormal_cardiac_muscle | 1.67142839 |
| 39 | MP0009697_abnormal_copulation | 1.66109845 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.62904028 |
| 41 | MP0002572_abnormal_emotion/affect_behav | 1.60077845 |
| 42 | MP0003137_abnormal_impulse_conducting | 1.58666761 |
| 43 | MP0004233_abnormal_muscle_weight | 1.57166488 |
| 44 | MP0004085_abnormal_heartbeat | 1.55067118 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.49262264 |
| 46 | MP0005670_abnormal_white_adipose | 1.46887687 |
| 47 | MP0003121_genomic_imprinting | 1.43372534 |
| 48 | MP0004924_abnormal_behavior | 1.43257391 |
| 49 | MP0005386_behavior/neurological_phenoty | 1.43257391 |
| 50 | MP0001486_abnormal_startle_reflex | 1.42651505 |
| 51 | MP0004087_abnormal_muscle_fiber | 1.42534587 |
| 52 | MP0002106_abnormal_muscle_physiology | 1.42311529 |
| 53 | MP0000747_muscle_weakness | 1.41825174 |
| 54 | MP0002269_muscular_atrophy | 1.41577410 |
| 55 | MP0005535_abnormal_body_temperature | 1.40003269 |
| 56 | MP0002067_abnormal_sensory_capabilities | 1.39646814 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.38173559 |
| 58 | MP0003567_abnormal_fetal_cardiomyocyte | 1.36430646 |
| 59 | MP0001529_abnormal_vocalization | 1.35551358 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.33176091 |
| 61 | MP0008569_lethality_at_weaning | 1.32927026 |
| 62 | MP0006035_abnormal_mitochondrial_morpho | 1.31334708 |
| 63 | MP0005394_taste/olfaction_phenotype | 1.29653184 |
| 64 | MP0005499_abnormal_olfactory_system | 1.29653184 |
| 65 | MP0003011_delayed_dark_adaptation | 1.29057460 |
| 66 | MP0003879_abnormal_hair_cell | 1.28544589 |
| 67 | MP0002735_abnormal_chemical_nociception | 1.28088254 |
| 68 | MP0003122_maternal_imprinting | 1.26173790 |
| 69 | MP0005187_abnormal_penis_morphology | 1.24792391 |
| 70 | MP0005083_abnormal_biliary_tract | 1.23520724 |
| 71 | MP0000569_abnormal_digit_pigmentation | 1.20605558 |
| 72 | MP0005385_cardiovascular_system_phenoty | 1.19391694 |
| 73 | MP0001544_abnormal_cardiovascular_syste | 1.19391694 |
| 74 | MP0003186_abnormal_redox_activity | 1.17441844 |
| 75 | MP0005369_muscle_phenotype | 1.17195051 |
| 76 | MP0002653_abnormal_ependyma_morphology | 1.17185327 |
| 77 | MP0000759_abnormal_skeletal_muscle | 1.17126889 |
| 78 | MP0001440_abnormal_grooming_behavior | 1.16544718 |
| 79 | MP0008789_abnormal_olfactory_epithelium | 1.13760331 |
| 80 | MP0006138_congestive_heart_failure | 1.10697319 |
| 81 | MP0003221_abnormal_cardiomyocyte_apopto | 1.09604386 |
| 82 | MP0008961_abnormal_basal_metabolism | 1.06932672 |
| 83 | MP0003890_abnormal_embryonic-extraembry | 1.06212567 |
| 84 | MP0004133_heterotaxia | 1.06117891 |
| 85 | MP0008058_abnormal_DNA_repair | 1.05616880 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 1.04987138 |
| 87 | MP0008995_early_reproductive_senescence | 1.04730323 |
| 88 | MP0001970_abnormal_pain_threshold | 1.04140837 |
| 89 | MP0005253_abnormal_eye_physiology | 1.01961488 |
| 90 | MP0003195_calcinosis | 1.01810806 |
| 91 | MP0004142_abnormal_muscle_tone | 1.00265827 |
| 92 | MP0003787_abnormal_imprinting | 0.99596003 |
| 93 | MP0000230_abnormal_systemic_arterial | 0.99346707 |
| 94 | MP0004811_abnormal_neuron_physiology | 0.99142887 |
| 95 | MP0005464_abnormal_platelet_physiology | 0.98184388 |
| 96 | MP0001765_abnormal_ion_homeostasis | 0.96940267 |
| 97 | MP0002733_abnormal_thermal_nociception | 0.95923640 |
| 98 | MP0006276_abnormal_autonomic_nervous | 0.94249182 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.93807868 |
| 100 | MP0002234_abnormal_pharynx_morphology | 0.92922388 |
| 101 | MP0002557_abnormal_social/conspecific_i | 0.92691530 |
| 102 | MP0001502_abnormal_circadian_rhythm | 0.90750368 |
| 103 | MP0000003_abnormal_adipose_tissue | 0.90743829 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.90333296 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.90332322 |
| 106 | MP0010386_abnormal_urinary_bladder | 0.89660084 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.88433410 |
| 108 | MP0002066_abnormal_motor_capabilities/c | 0.88025713 |
| 109 | MP0000778_abnormal_nervous_system | 0.87238551 |
| 110 | MP0005645_abnormal_hypothalamus_physiol | 0.86771152 |
| 111 | MP0000631_abnormal_neuroendocrine_gland | 0.86644201 |
| 112 | MP0001905_abnormal_dopamine_level | 0.86473384 |
| 113 | MP0006292_abnormal_olfactory_placode | 0.85708521 |
| 114 | MP0003633_abnormal_nervous_system | 0.85564746 |
| 115 | MP0008872_abnormal_physiological_respon | 0.84206705 |
| 116 | MP0002638_abnormal_pupillary_reflex | 0.83082243 |
| 117 | MP0000750_abnormal_muscle_regeneration | 0.81669720 |
| 118 | MP0001485_abnormal_pinna_reflex | 0.79982502 |
| 119 | MP0005423_abnormal_somatic_nervous | 0.78961658 |
| 120 | MP0005636_abnormal_mineral_homeostasis | 0.77972991 |
| 121 | MP0002184_abnormal_innervation | 0.77232066 |
| 122 | MP0003136_yellow_coat_color | 0.75692109 |
| 123 | MP0002971_abnormal_brown_adipose | 0.75555731 |
| 124 | MP0010630_abnormal_cardiac_muscle | 0.75024822 |
| 125 | MP0002882_abnormal_neuron_morphology | 0.74412349 |
| 126 | MP0005448_abnormal_energy_balance | 0.74122377 |
| 127 | MP0003329_amyloid_beta_deposits | 0.73995549 |
| 128 | MP0002069_abnormal_eating/drinking_beha | 0.73398439 |
| 129 | MP0005666_abnormal_adipose_tissue | 0.73208138 |
| 130 | MP0002127_abnormal_cardiovascular_syste | 0.72368531 |
| 131 | MP0005085_abnormal_gallbladder_physiolo | 0.70796046 |
| 132 | MP0003953_abnormal_hormone_level | 0.70661115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.94974058 |
| 2 | Exercise-induced myalgia (HP:0003738) | 4.81727781 |
| 3 | Myoglobinuria (HP:0002913) | 4.16465070 |
| 4 | Sudden death (HP:0001699) | 3.89038715 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 3.67539979 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.58809729 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 3.55831790 |
| 8 | Visual hallucinations (HP:0002367) | 3.55783948 |
| 9 | Febrile seizures (HP:0002373) | 3.39846240 |
| 10 | Acute necrotizing encephalopathy (HP:0006965) | 3.39319712 |
| 11 | Atonic seizures (HP:0010819) | 3.35972566 |
| 12 | Hyperalaninemia (HP:0003348) | 3.35205239 |
| 13 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.35205239 |
| 14 | Abnormality of alanine metabolism (HP:0010916) | 3.35205239 |
| 15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.34656652 |
| 16 | Myokymia (HP:0002411) | 3.21888213 |
| 17 | Nemaline bodies (HP:0003798) | 3.19674223 |
| 18 | Bundle branch block (HP:0011710) | 3.15784020 |
| 19 | Acute encephalopathy (HP:0006846) | 3.13082506 |
| 20 | Ketoacidosis (HP:0001993) | 3.12902471 |
| 21 | Pheochromocytoma (HP:0002666) | 3.11745003 |
| 22 | Palpitations (HP:0001962) | 3.08007072 |
| 23 | Atrial fibrillation (HP:0005110) | 3.06276106 |
| 24 | Hepatic necrosis (HP:0002605) | 3.03635419 |
| 25 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.99307281 |
| 26 | Oligomenorrhea (HP:0000876) | 2.98663991 |
| 27 | Progressive macrocephaly (HP:0004481) | 2.95528013 |
| 28 | Epileptic encephalopathy (HP:0200134) | 2.93949792 |
| 29 | Focal seizures (HP:0007359) | 2.91736756 |
| 30 | Syncope (HP:0001279) | 2.90882121 |
| 31 | Neuroendocrine neoplasm (HP:0100634) | 2.89493705 |
| 32 | Primary atrial arrhythmia (HP:0001692) | 2.86600147 |
| 33 | Hepatocellular necrosis (HP:0001404) | 2.84865580 |
| 34 | Abnormality of the calf musculature (HP:0001430) | 2.83217584 |
| 35 | Generalized tonic-clonic seizures (HP:0002069) | 2.81167337 |
| 36 | Absence seizures (HP:0002121) | 2.77674617 |
| 37 | Supraventricular tachycardia (HP:0004755) | 2.75088526 |
| 38 | Ventricular fibrillation (HP:0001663) | 2.73756327 |
| 39 | Rhabdomyolysis (HP:0003201) | 2.73597380 |
| 40 | Mitochondrial inheritance (HP:0001427) | 2.73213683 |
| 41 | Prolonged QT interval (HP:0001657) | 2.72516456 |
| 42 | Cholelithiasis (HP:0001081) | 2.70025762 |
| 43 | Lactic acidosis (HP:0003128) | 2.67825698 |
| 44 | Supraventricular arrhythmia (HP:0005115) | 2.67721213 |
| 45 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.62626523 |
| 46 | Increased CSF lactate (HP:0002490) | 2.59842238 |
| 47 | Gout (HP:0001997) | 2.59181297 |
| 48 | Type II lissencephaly (HP:0007260) | 2.58047788 |
| 49 | Increased muscle lipid content (HP:0009058) | 2.56712457 |
| 50 | Anxiety (HP:0000739) | 2.56621469 |
| 51 | Central scotoma (HP:0000603) | 2.56298857 |
| 52 | Depression (HP:0000716) | 2.53163270 |
| 53 | Myotonia (HP:0002486) | 2.51553486 |
| 54 | Hypoglycemic coma (HP:0001325) | 2.48187966 |
| 55 | Limb dystonia (HP:0002451) | 2.46923274 |
| 56 | Abnormal EKG (HP:0003115) | 2.45885548 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 2.44371789 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.43533795 |
| 59 | Muscle stiffness (HP:0003552) | 2.41743260 |
| 60 | Dysmetric saccades (HP:0000641) | 2.41706805 |
| 61 | Hyperventilation (HP:0002883) | 2.41418903 |
| 62 | Ketosis (HP:0001946) | 2.41110056 |
| 63 | Rimmed vacuoles (HP:0003805) | 2.40833199 |
| 64 | Dialeptic seizures (HP:0011146) | 2.40366506 |
| 65 | Cerebral edema (HP:0002181) | 2.37381171 |
| 66 | Left ventricular hypertrophy (HP:0001712) | 2.36114327 |
| 67 | 3-Methylglutaconic aciduria (HP:0003535) | 2.34609233 |
| 68 | Heart block (HP:0012722) | 2.33264409 |
| 69 | Gait imbalance (HP:0002141) | 2.30710401 |
| 70 | Ragged-red muscle fibers (HP:0003200) | 2.28841788 |
| 71 | Increased intramyocellular lipid droplets (HP:0012240) | 2.27062309 |
| 72 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.24285300 |
| 73 | Metaphyseal dysplasia (HP:0100255) | 2.23723681 |
| 74 | Lissencephaly (HP:0001339) | 2.22149862 |
| 75 | Poor eye contact (HP:0000817) | 2.21902445 |
| 76 | Poikilocytosis (HP:0004447) | 2.21602715 |
| 77 | Impaired social interactions (HP:0000735) | 2.20396997 |
| 78 | Abnormal social behavior (HP:0012433) | 2.20396997 |
| 79 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.20266891 |
| 80 | Cholecystitis (HP:0001082) | 2.20146216 |
| 81 | Abnormal gallbladder physiology (HP:0012438) | 2.20146216 |
| 82 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.18237476 |
| 83 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.18237476 |
| 84 | Asymmetric septal hypertrophy (HP:0001670) | 2.16444092 |
| 85 | Ventricular arrhythmia (HP:0004308) | 2.16036172 |
| 86 | EMG: myopathic abnormalities (HP:0003458) | 2.15306424 |
| 87 | Ventricular tachycardia (HP:0004756) | 2.14466116 |
| 88 | Hyperglycinemia (HP:0002154) | 2.14386204 |
| 89 | Polyphagia (HP:0002591) | 2.12335987 |
| 90 | Congenital primary aphakia (HP:0007707) | 2.11092497 |
| 91 | Exercise intolerance (HP:0003546) | 2.09690222 |
| 92 | Abnormal atrioventricular conduction (HP:0005150) | 2.09261397 |
| 93 | Lipoatrophy (HP:0100578) | 2.09131814 |
| 94 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.08730289 |
| 95 | Subaortic stenosis (HP:0001682) | 2.08730289 |
| 96 | Methylmalonic acidemia (HP:0002912) | 2.08691589 |
| 97 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.08119324 |
| 98 | Increased hepatocellular lipid droplets (HP:0006565) | 2.07187984 |
| 99 | Muscle fiber splitting (HP:0003555) | 2.07123992 |
| 100 | Urinary urgency (HP:0000012) | 2.06666758 |
| 101 | Papillary thyroid carcinoma (HP:0002895) | 2.06574274 |
| 102 | Abnormality of the labia minora (HP:0012880) | 2.06469203 |
| 103 | Dicarboxylic aciduria (HP:0003215) | 2.06054086 |
| 104 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.06054086 |
| 105 | Renal Fanconi syndrome (HP:0001994) | 2.04702249 |
| 106 | Athetosis (HP:0002305) | 2.04483560 |
| 107 | Nephrogenic diabetes insipidus (HP:0009806) | 2.03875178 |
| 108 | Broad-based gait (HP:0002136) | 2.03724303 |
| 109 | Abnormality of midbrain morphology (HP:0002418) | 2.03381295 |
| 110 | Molar tooth sign on MRI (HP:0002419) | 2.03381295 |
| 111 | Progressive cerebellar ataxia (HP:0002073) | 2.02813108 |
| 112 | Lipid accumulation in hepatocytes (HP:0006561) | 2.02674911 |
| 113 | Acanthocytosis (HP:0001927) | 2.02262848 |
| 114 | Neoplasm of the adrenal gland (HP:0100631) | 2.01408007 |
| 115 | Atrioventricular block (HP:0001678) | 1.99483233 |
| 116 | Tinnitus (HP:0000360) | 1.98636923 |
| 117 | Dilated cardiomyopathy (HP:0001644) | 1.97703541 |
| 118 | Hyperlipoproteinemia (HP:0010980) | 1.97590885 |
| 119 | Retinal dysplasia (HP:0007973) | 1.97396564 |
| 120 | Metabolic acidosis (HP:0001942) | 1.96117392 |
| 121 | Conjunctival hamartoma (HP:0100780) | 1.95646967 |
| 122 | Muscle fiber inclusion bodies (HP:0100299) | 1.95615006 |
| 123 | Cerebral hypomyelination (HP:0006808) | 1.95322584 |
| 124 | Abnormality of glycolysis (HP:0004366) | 1.93840099 |
| 125 | Increased serum pyruvate (HP:0003542) | 1.93840099 |
| 126 | Pancreatic cysts (HP:0001737) | 1.93656441 |
| 127 | Generalized aminoaciduria (HP:0002909) | 1.91086345 |
| 128 | Abnormality of serum amino acid levels (HP:0003112) | 1.90461054 |
| 129 | Progressive inability to walk (HP:0002505) | 1.90133456 |
| 130 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.89942836 |
| 131 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.89752461 |
| 132 | Gaze-evoked nystagmus (HP:0000640) | 1.89569938 |
| 133 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.87660267 |
| 134 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.87660267 |
| 135 | Delusions (HP:0000746) | 1.85901246 |
| 136 | Epileptiform EEG discharges (HP:0011182) | 1.82736840 |
| 137 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.82508447 |
| 138 | Abnormality of glycine metabolism (HP:0010895) | 1.82508447 |
| 139 | Hypsarrhythmia (HP:0002521) | 1.82477966 |
| 140 | Renal cortical cysts (HP:0000803) | 1.80729385 |
| 141 | Drooling (HP:0002307) | 1.80209730 |
| 142 | Hyperglycinuria (HP:0003108) | 1.80177379 |
| 143 | Thyroid carcinoma (HP:0002890) | 1.78507531 |
| 144 | Inability to walk (HP:0002540) | 1.76962754 |
| 145 | Genital tract atresia (HP:0001827) | 1.76349774 |
| 146 | EEG with generalized epileptiform discharges (HP:0011198) | 1.76107262 |
| 147 | Increased serum lactate (HP:0002151) | 1.74781890 |
| 148 | True hermaphroditism (HP:0010459) | 1.74504510 |
| 149 | Vaginal atresia (HP:0000148) | 1.73290203 |
| 150 | Hypomagnesemia (HP:0002917) | 1.72989164 |
| 151 | Abnormality of the corticospinal tract (HP:0002492) | 1.72935401 |
| 152 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.72872918 |
| 153 | Unsteady gait (HP:0002317) | 1.72691766 |
| 154 | Pancreatic fibrosis (HP:0100732) | 1.72569247 |
| 155 | Postnatal microcephaly (HP:0005484) | 1.69761790 |
| 156 | Leukodystrophy (HP:0002415) | 1.69583514 |
| 157 | Specific learning disability (HP:0001328) | 1.68229607 |
| 158 | Gonadotropin excess (HP:0000837) | 1.65669074 |
| 159 | Spastic gait (HP:0002064) | 1.65359321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK4 | 3.28420944 |
| 2 | PDK3 | 3.28420944 |
| 3 | NTRK3 | 2.90131295 |
| 4 | TRIM28 | 2.87138429 |
| 5 | MAP3K12 | 2.81887060 |
| 6 | PINK1 | 2.50840206 |
| 7 | MAP4K2 | 2.45454165 |
| 8 | EPHA4 | 2.37622325 |
| 9 | MAP3K4 | 2.35770121 |
| 10 | MAP3K9 | 2.30977999 |
| 11 | OBSCN | 2.27892087 |
| 12 | PHKG2 | 2.24578026 |
| 13 | PHKG1 | 2.24578026 |
| 14 | BCKDK | 2.19987226 |
| 15 | MST4 | 2.18910765 |
| 16 | BCR | 2.18477891 |
| 17 | MAP2K7 | 2.17531932 |
| 18 | EIF2AK1 | 2.11505882 |
| 19 | MAP2K4 | 2.08466483 |
| 20 | LMTK2 | 2.07356355 |
| 21 | NEK1 | 2.06801417 |
| 22 | PDK2 | 1.99635719 |
| 23 | PRKD3 | 1.99323016 |
| 24 | ERBB3 | 1.95542361 |
| 25 | MARK1 | 1.92106055 |
| 26 | DAPK2 | 1.89476949 |
| 27 | TIE1 | 1.74912656 |
| 28 | TAOK3 | 1.73997302 |
| 29 | ARAF | 1.73795674 |
| 30 | INSRR | 1.73461056 |
| 31 | MINK1 | 1.67651749 |
| 32 | CSNK1G1 | 1.60254686 |
| 33 | MYLK | 1.59006484 |
| 34 | BMPR1B | 1.55724953 |
| 35 | DYRK2 | 1.45994175 |
| 36 | KSR2 | 1.45598099 |
| 37 | TRIB3 | 1.44572201 |
| 38 | CAMKK1 | 1.40332026 |
| 39 | DYRK3 | 1.39779305 |
| 40 | ZAK | 1.38244149 |
| 41 | CDK19 | 1.36983846 |
| 42 | CSNK1G2 | 1.36547222 |
| 43 | MUSK | 1.34868683 |
| 44 | SGK2 | 1.34619403 |
| 45 | TNIK | 1.27342246 |
| 46 | PKN2 | 1.26226513 |
| 47 | GRK5 | 1.24999717 |
| 48 | SGK223 | 1.24848359 |
| 49 | SGK494 | 1.24848359 |
| 50 | DAPK1 | 1.22758172 |
| 51 | CSNK1G3 | 1.22512814 |
| 52 | CASK | 1.21966680 |
| 53 | PRPF4B | 1.20337128 |
| 54 | PLK2 | 1.19345274 |
| 55 | CAMKK2 | 1.18461440 |
| 56 | PLK3 | 1.17881146 |
| 57 | NME1 | 1.17835442 |
| 58 | STK16 | 1.15760862 |
| 59 | TTN | 1.13178343 |
| 60 | STK38 | 1.12903887 |
| 61 | PTK2B | 1.12468376 |
| 62 | TAOK1 | 1.11167061 |
| 63 | NLK | 1.08465820 |
| 64 | EPHA3 | 1.06064591 |
| 65 | SGK3 | 1.05691954 |
| 66 | PBK | 1.04014548 |
| 67 | PAK6 | 1.03305618 |
| 68 | CCNB1 | 1.00351465 |
| 69 | MAP3K13 | 0.99727244 |
| 70 | GRK7 | 0.98592352 |
| 71 | CSNK1A1L | 0.98567049 |
| 72 | SRPK1 | 0.96647191 |
| 73 | CAMK1 | 0.92231628 |
| 74 | MKNK2 | 0.90729200 |
| 75 | CDK5 | 0.89520772 |
| 76 | ACVR1B | 0.89210566 |
| 77 | VRK1 | 0.88436711 |
| 78 | PDK1 | 0.88375987 |
| 79 | PRKCG | 0.87631186 |
| 80 | KSR1 | 0.86719513 |
| 81 | MAP2K1 | 0.84712661 |
| 82 | WNK4 | 0.84301796 |
| 83 | CAMK2A | 0.84152686 |
| 84 | TSSK6 | 0.83639413 |
| 85 | MAP3K1 | 0.83150728 |
| 86 | STK24 | 0.83050435 |
| 87 | MKNK1 | 0.83010168 |
| 88 | BRAF | 0.82625394 |
| 89 | GRK1 | 0.82059371 |
| 90 | WNK3 | 0.81191784 |
| 91 | MAPK12 | 0.80685016 |
| 92 | UHMK1 | 0.78659994 |
| 93 | BMPR2 | 0.78353468 |
| 94 | CAMK2D | 0.77943417 |
| 95 | TNK2 | 0.75396756 |
| 96 | PRKAA1 | 0.75211527 |
| 97 | PDPK1 | 0.74946195 |
| 98 | RPS6KA5 | 0.71361271 |
| 99 | SGK1 | 0.66859860 |
| 100 | EIF2AK3 | 0.66547379 |
| 101 | LIMK1 | 0.66462154 |
| 102 | NUAK1 | 0.66360593 |
| 103 | RPS6KA4 | 0.66341343 |
| 104 | MAPK13 | 0.64906111 |
| 105 | MAP3K7 | 0.63667195 |
| 106 | CAMK2G | 0.63652388 |
| 107 | PRKCH | 0.61637326 |
| 108 | ADRBK2 | 0.61397819 |
| 109 | CDK3 | 0.61386871 |
| 110 | RIPK4 | 0.60842982 |
| 111 | SIK3 | 0.60266443 |
| 112 | PIK3CA | 0.59919796 |
| 113 | MAPKAPK3 | 0.55019488 |
| 114 | RET | 0.52863759 |
| 115 | CAMK4 | 0.51525310 |
| 116 | NTRK2 | 0.50569542 |
| 117 | TAOK2 | 0.50440082 |
| 118 | MAP3K11 | 0.50312651 |
| 119 | DMPK | 0.50239068 |
| 120 | PAK3 | 0.48946588 |
| 121 | PKN1 | 0.48712900 |
| 122 | RIPK1 | 0.48584383 |
| 123 | AKT3 | 0.47724968 |
| 124 | PNCK | 0.47707324 |
| 125 | MAP3K5 | 0.47178671 |
| 126 | TEC | 0.46867767 |
| 127 | CDC7 | 0.46717814 |
| 128 | PIK3CG | 0.46631887 |
| 129 | TXK | 0.46132971 |
| 130 | PRKCE | 0.45730702 |
| 131 | PRKG1 | 0.45426931 |
| 132 | FER | 0.45231678 |
| 133 | OXSR1 | 0.45177897 |
| 134 | DYRK1B | 0.44997592 |
| 135 | CDC42BPA | 0.44453606 |
| 136 | PRKACG | 0.44422100 |
| 137 | PLK1 | 0.44242152 |
| 138 | PRKACA | 0.44136349 |
| 139 | STK4 | 0.43243435 |
| 140 | DYRK1A | 0.43190409 |
| 141 | MAP2K3 | 0.42629137 |
| 142 | FRK | 0.41161007 |
| 143 | PRKAA2 | 0.41141172 |
| 144 | CAMK2B | 0.40880162 |
| 145 | WEE1 | 0.40454395 |
| 146 | RPS6KA3 | 0.39969875 |
| 147 | CSNK1D | 0.39902398 |
| 148 | ADRBK1 | 0.33276717 |
| 149 | PLK4 | 0.31136504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.66156363 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.69897376 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.58439755 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.40669090 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.35476119 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.25727113 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.24114923 |
| 8 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.23556589 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.19711437 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.10658414 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.06795387 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.94721858 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.90710662 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 1.89432319 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.86570181 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.83216930 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.80833666 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.76187279 |
| 19 | Morphine addiction_Homo sapiens_hsa05032 | 1.73852607 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.61208297 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.60310350 |
| 22 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.59386982 |
| 23 | Carbon metabolism_Homo sapiens_hsa01200 | 1.55797470 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.54204892 |
| 25 | Long-term potentiation_Homo sapiens_hsa04720 | 1.53866977 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.52521305 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51478224 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51012166 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42117173 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41869646 |
| 31 | Salivary secretion_Homo sapiens_hsa04970 | 1.40064310 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.37114651 |
| 33 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.36559583 |
| 34 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.34014399 |
| 35 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.33924228 |
| 36 | Proteasome_Homo sapiens_hsa03050 | 1.33692449 |
| 37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.32192808 |
| 38 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.30117865 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29848950 |
| 40 | Renin secretion_Homo sapiens_hsa04924 | 1.27778420 |
| 41 | Taste transduction_Homo sapiens_hsa04742 | 1.27436866 |
| 42 | RNA degradation_Homo sapiens_hsa03018 | 1.26613453 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26509392 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 1.25754963 |
| 45 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.24392726 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.22916356 |
| 47 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.18449546 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.17799246 |
| 49 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.16544221 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13531776 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13459671 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.12904108 |
| 53 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.12717953 |
| 54 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.10923393 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.09533617 |
| 56 | Alcoholism_Homo sapiens_hsa05034 | 1.06162271 |
| 57 | RNA polymerase_Homo sapiens_hsa03020 | 1.05944774 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04196808 |
| 59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03625043 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01176544 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00063260 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96606558 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96448615 |
| 64 | Basal transcription factors_Homo sapiens_hsa03022 | 0.93674095 |
| 65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.88905177 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88380184 |
| 67 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.87635632 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84361047 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.83755431 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80790591 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.79666694 |
| 72 | Cocaine addiction_Homo sapiens_hsa05030 | 0.79465107 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77685188 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75760448 |
| 75 | Purine metabolism_Homo sapiens_hsa00230 | 0.74969745 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72191641 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.71812561 |
| 78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71532006 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 0.70434547 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69550092 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69169762 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67757893 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67497212 |
| 84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67356644 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67350870 |
| 86 | RNA transport_Homo sapiens_hsa03013 | 0.67285283 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66796195 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66605196 |
| 89 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.66100004 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66038457 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65815742 |
| 92 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65676808 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | 0.65157515 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64314873 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63345580 |
| 96 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63320742 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61913511 |
| 98 | Mismatch repair_Homo sapiens_hsa03430 | 0.60931101 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60873997 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60188667 |
| 101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.58054985 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.57565969 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57224790 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.56975116 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55595636 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55420956 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55312724 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54461999 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52518180 |
| 110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52410470 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52042964 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51863358 |
| 113 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51427642 |
| 114 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51386495 |
| 115 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51167475 |
| 116 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50954959 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50482582 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49085609 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49082510 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48109322 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47986022 |
| 122 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47891416 |
| 123 | Peroxisome_Homo sapiens_hsa04146 | 0.46608799 |
| 124 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44277192 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43658306 |
| 126 | Phototransduction_Homo sapiens_hsa04744 | 0.43470837 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38854572 |
| 128 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38741508 |
| 129 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37006275 |
| 130 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.35332311 |
| 131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35292808 |
| 132 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.33560214 |
| 133 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.32737523 |

